Answer
Mirikizumab selectively binds the p19 subunit of interleukin-23 (IL-23), blocking its interaction with the IL-23 receptor.
Sources for this answer
- Omvoh 100 mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked